In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

In a phase I clinical trial, nine adults with kidney cancer were treated with a personalized cancer vaccine that targets neoantigens (mutant proteins expressed by tumour cells). The vaccine ...

Vaccines for cancer may have seem like a pipe dream a few years ago, but with the great work of scientists and researchers we have made great strides towards cancer treatments. This new vaccine may be ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

A personalized vaccine against advanced kidney cancer has shown encouraging results in a clinical trial, with all nine ...